BIOMAT Database Logo BIOMAT Database Logo

Cefepime-Induced Neurotoxicity: An Underappreciated Cause of Encephalopathy. 2019

Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Department of Medicine, St. Vincent's Medical Center, Bridgeport, CT.

UI MeSH Term Description Entries
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077723 Cefepime A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA. Axépim,BMY 28142,BMY-28142,Cefepim,Cefepime Hydrochloride,Maxipime,Quadrocef,BMY28142
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D020258 Neurotoxicity Syndromes Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. Poisoning, Nervous System,Encephalopathy, Toxic,Nervous System Poisoning,Neurotoxic Disorders,Neurotoxin Diseases,Neurotoxin Disorders,Toxic Encephalitis,Encephalitides, Toxic,Encephalitis, Toxic,Encephalopathies, Toxic,Nervous System Poisonings,Neurotoxic Disorder,Neurotoxicity Syndrome,Neurotoxin Disease,Neurotoxin Disorder,Poisonings, Nervous System,Syndrome, Neurotoxicity,Syndromes, Neurotoxicity,Toxic Encephalitides,Toxic Encephalopathies,Toxic Encephalopathy

Related Publications

Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
November 2013, Critical care (London, England),
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-Induced Encephalopathy: A Possible Additional Mechanism of Neurotoxicity.
April 2020, Neurocritical care,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-Induced Encephalopathy: Could Carnitine Deficiency Contribute to Neurotoxicity?
April 2020, The Neurohospitalist,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-Induced Neurotoxicity.
September 2021, Cureus,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Response to "Cefepime-Induced Encephalopathy: A Possible Additional Mechanism of Neurotoxicity".
April 2020, Neurocritical care,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-Induced Encephalopathy.
February 2021, Cureus,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
[Cefepime-induced encephalopathy].
November 2019, Revue medicale suisse,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-induced encephalopathy.
January 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime-induced encephalopathy.
February 2018, BMJ case reports,
Ankita Subedi, and Swachchhanda Songmen, and Venkanta Manchala, and Joseph Mattana
Cefepime: a rare cause of encephalopathy.
June 2012, Internal medicine journal,
Copied contents to your clipboard!